Akari Therapeutics Plc (AKTX)
10.37
-0.06
(-0.58%)
USD |
NASDAQ |
Sep 01, 16:00
10.25
-0.12
(-1.16%)
After-Hours: 20:00
Akari Therapeutics Cash from Operations (TTM) : -10.74M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.74M |
| March 31, 2026 | -10.93M |
| December 31, 2025 | -10.59M |
| September 30, 2025 | -9.678M |
| June 30, 2025 | -9.066M |
| March 31, 2025 | -10.66M |
| December 31, 2024 | -12.55M |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -20.19M |
| March 31, 2022 | -16.48M |
| December 31, 2021 | -18.85M |
| September 30, 2021 | -18.08M |
| June 30, 2021 | -17.22M |
| March 31, 2021 | -16.63M |
| Date | Value |
|---|---|
| December 31, 2020 | -16.95M |
| September 30, 2020 | -16.18M |
| June 30, 2020 | -20.39M |
| March 31, 2020 | -20.89M |
| December 31, 2019 | -12.92M |
| September 30, 2019 | -14.02M |
| June 30, 2019 | -14.44M |
| March 31, 2019 | -17.95M |
| December 31, 2018 | -22.58M |
| September 30, 2018 | -26.53M |
| June 30, 2018 | -30.41M |
| March 31, 2018 | -26.83M |
| December 31, 2017 | -31.60M |
| September 30, 2017 | -29.47M |
| June 30, 2017 | -25.25M |
| March 31, 2017 | -26.63M |
| December 31, 2016 | -24.52M |
| September 30, 2016 | -24.89M |
| June 30, 2016 | -14.72M |
| March 31, 2016 | -9.961M |
| December 31, 2015 | -4.964M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| DBV Technologies SA | -169.35M |
| Cellectis SA | -42.00M |
| argenx SE | 1.160B |
| Autolus Therapeutics Plc | -224.98M |
| Evaxion AS | -- |